Loading...
Enerpac delivered a strong Q3 FY25, with higher revenue, solid EPS, and expanded adjusted margins despite ongoing macroeconomic uncertainties.
Reported revenue of $158.7M, up 5.5% YoY
Adjusted EPS reached $0.51 on strong operational performance
Adjusted EBITDA margin improved to 25.9%
Cortland Biomedical revenue grew 18.7% YoY
Enerpac maintained its FY25 guidance but expects results to land in the lower half of the range due to macroeconomic headwinds.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance